Subscribe to Newsletter
Manufacture Vaccines

Green Light for Malaria Vaccine

| Stephanie Vine

After 28 years of R&D at GSK, the world has its first malaria vaccine.

Manufacture Small Molecules

Highly Potent; Highly Targeted

| Stephanie Vine

A new mathematical model aims to improve drugs for cancer, viruses and bacteria.

Business & Regulation Business Practice

The Epidemic That Cannot Be Ignored

| Charlotte Barker

The US Centers for Disease Control and Prevention has officially declared an “epidemic of prescription drug abuse”.

Manufacture Business Practice

Protein stability measurements amplified: Combining SEC-MALS and DLS to maximize data output

| Sponsored by Malvern Panalytical

The stability of a protein sample and its tendency to aggregate is explored using a combination of SEC-MALS and DLS

Manufacture Biosimilars

Taylor Dispersion Analysis for assessing the self-association and stability of Insulin

| Sponsored by Malvern Panalytical

Taylor Dispersion measurements are used to monitor self-association and oligomeric state in a variety of buffer conditions.

Manufacture Quality & Compliance

Architects of Quality

| Sponsored by Catalent

Quality by Design: we’ve all heard the phrase – and know we should be fully on board with the philosophy. But how?

Manufacture Small Molecules

Amine Alchemy

Complex amines from common chemicals - it's not magic, just clever chemistry.

Business & Regulation Business Practice

Eyes on Expansion

| Stephanie Vine

A round-up of the latest expansion plans and new facilities as building fever grips the industry

Manufacture Vaccines

Teaching Old Drugs New Tricks

| Stephanie Vine

Could existing drugs be repurposed as a shortcut to treating Ebola?

Business & Regulation Business Practice

The Innovation Game

| Stephanie Vine

Big pharma is turning to outside sources to fill pipelines, but how often are companies backing the wrong horse?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register